Form 4: Eli Lilly EVP & CIDO Diogo Rau Reports Stock Transactions

Diogo Rau, EVP & CIDO of Eli Lilly & Co, reports acquisition and disposal of common stock and acquisition of restricted stock units.

Summary

• On February 10, 2025, Diogo Rau, EVP & CIDO of Eli Lilly & Co, reported transactions involving Eli Lilly & Co [LLY] common stock and restricted stock units.
• Rau acquired 6,815.202 shares of common stock at a price of $868.88 per share.
• Rau also disposed of some shares, resulting in a total of 19,718.908 shares beneficially owned following the reported transactions.
• Additionally, Rau acquired 3,752 restricted stock units, each representing a contingent right to receive one share of Eli Lilly and Company common stock, exercisable and expiring on February 1, 2026.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral. It simply reports transactions.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by signaling management's confidence (or lack thereof) in the company, although individual transactions are unlikely to be significant.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Diogo Rau, LLY, Eli Lilly & Co, EVP & CIDO